skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Potent and selective mediators of cholesterol efflux

Patent ·
OSTI ID:1174197

The present invention provides a family of non-naturally occurring polypeptides having cholesterol efflux activity that parallels that of full-length apolipoproteins (e.g., Apo AI and Apo E), and having high selectivity for ABAC1 that parallels that of full-length apolipoproteins. The invention also provides compositions comprising such polypeptides, methods of identifying, screening and synthesizing such polypeptides, and methods of treating, preventing or diagnosing diseases and disorders associated with dyslipidemia, hypercholesterolemia and inflammation.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC02-05CH11231
Assignee:
The Regents of the University of California (Oakland, CA)
Patent Number(s):
8,987,192
Application Number:
12/519,116
OSTI ID:
1174197
Resource Relation:
Patent File Date: 2007 Dec 13
Country of Publication:
United States
Language:
English

References (11)

Characteristics of the amino acids as components of a peptide hormone sequence book January 1976
Protein Folding: A Glimpse of the Holy Grail? journal October 1998
Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox book January 1994
Limits of Cooperativity in a Structurally Modular Protein: Response of the Notch Ankyrin Domain to Analogous Alanine Substitutions in Each Repeat journal November 2002
Sustained-delivery of an apolipoproteinEā€“peptidomimetic using multivesicular liposomes lowers serum cholesterol levels journal February 2002
Effects of l- or d-Pro incorporation into hydrophobic or hydrophilic helix face of amphipathic Ī±-helical model peptide on structure and cell selectivity journal February 2004
Apolipoprotein E: phospholipid binding studies with synthetic peptides from the carboxyl terminus journal February 1992
Methods and reagents for modulating cholesterol levels patent-application March 2004
Helical synthetic peptides that stimulate cellular cholesterol efflux patent-application September 2005
Orally administered peptides synergize statin activity patent-application April 2008
Compositions and methods of use for treating cardiovascular disease patent-application September 2008